Skip to Content
Søk Menu

EADV20: Oral and topical treatment of Psoriasis now and in the future

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Related

Lisa Schots

Concentration of Ixekizumab Paving the Way Towards Personalized Therapy in Psoriasis

/ Lisa Schots
PsoriasisEADV23 Play the Video 1:37
Kim Papp

Deucravacitinib: Significantly Improved Symptoms and Signs of Psoriasis in Patients with Psoriasis

/ Kim Papp
PsoriasisEADV23 Play the Video 02:52
Enikö Sonkoly

New Oral Drug Sotyktu for Plaque Psoriasis Patients Demonstrates Promising Results with Favorable Safety Profile

/ Enikö Sonkoly
PsoriasisEADV23 Play the Video 3:38
Andreas Pinter

New and promising treatments for psoriasis

/ Andreas Pinter
PsoriasisEADV23 Play the Video 3:01
Kristian Reich

Latest advancements in the management of psoriasis: insights from EADV 2023

/ Kristian Reich
PsoriasisEADV23 Play the Video 3:11

Bimekixizumab: Blokade av både IL-17A og IL-17F. Hva betyr det for oss dermatologer og våre pasienter?

/ Kåre Steinar Tveit
DemensParkinsons sykdomIBDALSImmunologiMSPsoriasis

Why is Greenland a Paradise for a Dermatologist?

/ Carsten Sauer Mikkelsen
Psoriasis
Mallory Zaino

Barriers to outpatient dermatologic care

/ Mallory L. Zaino
Atopisk dermatittPsoriasis Play the Video 6:10

Do we Need to Re-think How we Deal with Psoriasis?

/ Carsten Sauer Mikkelsen / Lars Werner / Casper Bo Poulsen / Kristian Bakke Arvesen / Luit Penninga / Peter Bjerring
PsoriasisPRO-data
Back to top